Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo

被引:209
|
作者
Cheeseman, CI [1 ]
机构
[1] Univ Alberta, Dept Physiol, Membrane Transport Grp, Edmonton, AB T6G 2H7, Canada
关键词
sodium-dependent glucose transporter; glucagon-like peptide-2; membrane transport; protein trafficking;
D O I
10.1152/ajpregu.1997.273.6.R1965
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The effect of in vivo infusion of the peptide hormone glucagon-like peptide 2 (GLP-2) on glucose transport across the rat jejunal brush-border membrane (BBM) was assessed using isolated membrane vesicles. A 2-h infusion of GLP-2 produced a marked acceleration of sodium-dependent glucose uptake into BBM vesicles with a significant overshoot. There was no change in vesicle space or permeability resulting from the hormone infusion. Kinetic analysis showed this stimulation to be the result of a threefold increase in the maximal rate of transport, with no consistent change in the affinity constant (K-m). The time course of this response showed that the effect was observable, but smaller, after only 30 min of hormone infusion and was maximal after 1 h. Sodium-dependent phloridzin binding to the membrane vesicles showed a parallel increase in maximal binding after 1 and 2 h of hormone infusion. Western blotting showed a similar increase in sodium-dependent glucose transporter 1 (SGLT-1) abundance. The effect of GLP-2 could be blocked by luminal brefeldin A or wortmannin. These results indicate that GLP-2 is able to induce trafficking of SGLT-1 from an intracellular pool into the BBM within 60 min and that phosphoinositol 3-kinase may well be involved in the intracellular signaling pathway in this response.
引用
收藏
页码:R1965 / R1971
页数:7
相关论文
共 50 条
  • [21] Dopamine D-2 receptor upregulation in rat neostriatum following in vivo infusion of forskolin
    Wanderoy, MH
    WestlindDanielsson, A
    Ahlenius, S
    NEUROREPORT, 1997, 8 (13) : 2971 - 2976
  • [22] Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
    Mette Simone Aae Madsen
    Jacob Bak Holm
    Albert Pallejà
    Pernille Wismann
    Katrine Fabricius
    Kristoffer Rigbolt
    Martin Mikkelsen
    Morten Sommer
    Jacob Jelsing
    Henrik Bjørn Nielsen
    Niels Vrang
    Henrik H. Hansen
    Scientific Reports, 9
  • [23] Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
    Madsen, Mette Simone Aae
    Holm, Jacob Bak
    Palleja, Albert
    Wismann, Pernille
    Fabricius, Katrine
    Rigbolt, Kristoffer
    Mikkelsen, Martin
    Sommer, Morten
    Jelsing, Jacob
    Nielsen, Henrik Bjorn
    Vrang, Niels
    Hansen, Henrik H.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [24] Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine
    Kissow, Hannelouise
    Viby, Niels-Erik
    Hartmann, Bolette
    Holst, Jens Juul
    Timm, Michael
    Thim, Lars
    Poulsen, Steen Seier
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 39 - 48
  • [25] Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine
    Hannelouise Kissow
    Niels-Erik Viby
    Bolette Hartmann
    Jens Juul Holst
    Michael Timm
    Lars Thim
    Steen Seier Poulsen
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 39 - 48
  • [26] Basolateral D-glucose transport activity along the crypt-villus axis in rat jejunum and upregulation induced by gastric inhibitory peptide and glucagon-like peptide-2
    Cheeseman, CI
    O'Neill, D
    EXPERIMENTAL PHYSIOLOGY, 1998, 83 (05) : 605 - 616
  • [27] Dexamethasone and GLP-2 administered to rat dams during pregnancy and lactation have late effects on intestinal sugar transport in their postweanling offspring
    Drozdowski, Laurie A.
    Iordache, Claudiu
    Clandinin, M. Tom
    Todd, Zoe S. C.
    Gonnet, Maud
    Wild, Gary
    Uwiera, Richard R. E.
    Thomson, Alan B. R.
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2008, 19 (01): : 49 - 60
  • [28] Glucagon like peptide-2 (GLP-2) neither glicentin (GLI) nor GLP-1 enhanced ornithine decarboxylase (ODC) activity of both rat small intestinal mucosa and IEC-6.
    Hashimoto, A
    Naio, H
    Funayama, Y
    Fukushima, K
    Shibata, C
    Ogawa, H
    Ueno, T
    Kitayama, T
    Matsuno, S
    Sasaki, I
    GASTROENTEROLOGY, 2000, 118 (04) : A1514 - A1515
  • [29] The role of GLP-2 on oxidant-antioxidant system at an in vivo mouse model of intestinal injury induced by TNF-alpha/Act D
    Pirincci, P. Arda
    Bolkent, S.
    FEBS JOURNAL, 2009, 276 : 186 - 186
  • [30] The GLP1R agonist liraglutide inhibits hyperglucagonaemia induced by the SGLT2 inhibitor dapagliflozin
    Bonner, C.
    Saponaro, C.
    Gmyr, V.
    Moerman, E.
    Thevent, J.
    Delalleau, N.
    Pasquetti, G.
    Quenon, A.
    Kerr-Conte, J.
    Pattou, F.
    DIABETOLOGIA, 2017, 60 : S411 - S411